In the pathopysiology of T2DM, impaired insulin sensitivity and glucose intolerance are early phenomena, leading to hyperglycemia, hyperlipidemia and, eventually, to a failure of pancreatic beta cells to produce and secrete a sufficient amount of insulin. The gene discussed is INS; the disease is hyperlipidemia.